A 10-Step Guide on How to Create SDTM Datasets

Creating SDTM (Study Data Tabulation Model) datasets is a crucial step in the data management process of clinical trials. It organizes data in a standardized format. As a result, it streamlines the review and approval process for new treatments by regulatory agencies.

However, building SDTM datasets is more than just converting raw data into a specific format. You must have a deep understanding of the fundamental principles of SDTM, the particular requirements for different domains, and the practical steps involved in mapping, transforming, and validating data.

This guide will take you through every step. Keep reading to find out more!

1. Understand the CDISC SDTM Standards

CDISC, or the Clinical Data Interchange Standards Consortium, is a global, non-profit organization that develops and supports data standards that allow information system interoperability. SDTM standards, developed through collaboration among industry experts, regulators, and other contributors, are one of its key initiatives, defining a clear set of domains (such as demographics, adverse events, and lab results), each with specific variables and formats.

Now, here enters the conversion of raw clinical data into standardized datasets that adhere to these guidelines, ensuring that data submissions are accurate, complete, and easily interpretable by regulatory bodies like the FDA. This is vital for maintaining data quality and integrity throughout the clinical trial lifecycle. And achieving this doesn’t have to be difficult. You can make use of tools that allow for a much more streamlined and detailed SDTM dataset process. But always make sure you source them from a reputable provider.

2. Define Your Study Design

The study design of your clinical trial will influence the structure of your SDTM datasets. Outline the critical components, including the objectives, endpoints, population, and treatment arms. This information will help you determine the necessary domains and variables for your datasets.

A precise study design aids in accurately mapping source data to SDTM domains. Collaborate with study statisticians and clinical experts to ensure that it’s thoroughly reflected in your data collection efforts. This alignment ensures that your data is both comprehensive and relevant.

3. Collect Source Data

Source data is the raw data collected during your clinical trial. This includes information from case report forms (CRFs), electronic health records (EHRs), laboratory results, and other sources. Ensure that your source data is complete, accurate, and in a format that can be easily transformed into SDTM datasets.

Organizing and cleaning the source data is critical before mapping it to SDTM domains. Address any discrepancies, missing values, or errors. Consistently documenting the data collection process and any modifications made is also essential for transparency.

4. Map Source Data to SDTM Domains

Mapping your source data to SDTM domains is critical in the SDTM dataset process.

SDTM domains are predefined categories that organize data into logical groups, such as demographics (DM), adverse events (AE), and laboratory results (LB). Identify the appropriate ones for your source data and map each element to the corresponding SDTM variable.

Careful mapping involves understanding the nuances of each SDTM domain and how they relate to your source data. Tools and software designed explicitly for SDTM mapping can streamline this process. Moreover, regularly reviewing the mappings with clinical and data experts ensures accuracy and compliance.

5. Create Define.xml File

The define.xml file is an essential component of your SDTM submission. It provides metadata about your datasets, including information on the study design, domains, variables, and controlled terminology used. Use clinical SAS tools or specialized software to create an accurate define.xml file.

Furthermore, a well-prepared define.xml file not only facilitates the regulatory review process but also enhances the transparency of your study. This level of detail is crucial for ensuring that regulatory agencies can easily navigate and interpret your data. Meanwhile, consistently updating the define.xml file throughout the study helps maintain accuracy.

6. Generate SDTM Datasets

Using clinical SAS or other statistical programming languages, generate the SDTM datasets from your mapped source data. Ensure they adhere to the SDTM standards, with correct variable names, formats, and controlled terminology. Validate the datasets to check for compliance and accuracy.

7. Handle Adverse Events

Adverse events (AEs) are a critical aspect of clinical trial data. Ensure that they’re captured accurately in the AE domain, including information on the event description, onset and resolution dates, severity, relationship to the study drug, interventions taken, and outcome. Properly documenting AEs is vital for regulatory review and patient safety. Also, collaborating with clinical teams throughout the process can ensure accuracy.

8. Validate and Review SDTM Datasets

Validation is a crucial step to ensure your SDTM datasets are SDTM-compliant and free from errors. There are tools designed particularly for this, helping you identify any issues with the data structure, variable names, or controlled terminology. Also, involve data managers, statisticians, and other stakeholders to ensure completeness and accuracy.

In addition to automated validation checks, manual reviews provide an extra layer of assurance. Regularly update your validation protocols to align with evolving regulatory requirements and best practices

9. Prepare for Submission

Once your SDTM datasets are validated and reviewed, prepare them for submission to regulatory agencies. This includes compiling all required documents, such as the define.xml file, annotated CRFs, and other supporting documentation.

Organize your submission package systematically to ensure all necessary documents are included and easily accessible. Double-check that all files are in the correct formats and adhere to the specific guidelines provided by the regulatory agencies.

You can engage with regulatory submission experts to review your package and provide feedback.

10. Maintain Compliance and Continuous Improvement

Creating SDTM datasets is not a one-time task. You ought to maintain compliance with CDISC SDTM standards throughout your clinical trials. Also, continuously improve your processes by incorporating feedback from regulatory agencies and staying updated with changes in the standards.

Moreover, regular training and updates for your team will help maintain high-quality SDTM data. In addition to that, ensure that you consistently assess your data management practices to foster a culture of ongoing improvement. Engaging in industry forums and workshops is another must, allowing you to stay abreast of the latest developments in SDTM standards and best practices.

Conclusion

Creating SDTM datasets can be complex, but following these steps will help ensure your clinical trial data is accurately represented and ready for regulatory review. By understanding the data tabulation model, preparing your source data meticulously, and adhering to SDTM guidelines, you can streamline the process and increase the likelihood of a successful submission.